Caravaca-García A, Rodríguez-Fernández FA , Elhendi-Halawa W, Ruiz-Fito R

Language: Spanish
References: 14
Page: 114-117
PDF size: 687.16 Kb.

ABSTRACT

Acromegaly is a disease caused by a chronic increase of the growth hormone. This is usually due to a pituitary adenoma which also causes typical skeletal changes and also cardiovascular and metabolic alterations when the disease has progressed. Its low prevalence corresponds with the little experience acquired with this disease compared with other diseases more prevalent in the general population. We present the case of a 48-year-old male, who was operated of a bilateral cholesteatomatous chronic otitis media, with very advanced acromegaly and its very typical signs in face and skeleton.

REFERENCES

1. Reddy R, Hope S, Wass J. Acromegaly. BMJ 2010;16:341.

2. Sesmilo G, Webb SM, Neuroendocrinology Group of the Spanish Society of Endocrinology and Nutrition. Twelve years of the Spanish acromegaly registry: a historical view of acromegaly management in Spain. Endocrinol Nutr 2010;57:39-42.

3. Scacchi M, Cavagnini F. Acromegaly. Pituitary 2006;9:297-303.

4. Martínez-Delgado IA, Gómez-Martínez G. Acromegalia. Informe de 84 casos. Rev Med Inst Mex Seguro Soc 2008;46:311-314.

5. Ledón Llanes L, Agramonte Machado A, Fabré Redondo B, Hernández Rodríguez J. Impacto de la acromegalia y el síndrome de Cushing sobre la salud; una perspectiva vivencial. Rev Cubana de Endocrinol 2011;22:144-166.

6. Sociedad Mexicana de Nutrición y Endocrinología. Consenso Nacional de Acromegalia: Guía para su diagnóstico, tratamiento y seguimiento. Revista de Endocrinología y Nutrición 2004;12;supl 2.

7. Sharma D, Prabhakar H, Bithal PK, Ali Z, et al. Predicting difficult laryngoscopy in acromegaly: a comparison of upper lip bite test with modified Mallampati classification. J Neurosurg Anesthesiol 2010;22:138-143.

8. Peral AI. Comment on “an assessement of the predictors of difficult intubation in patients with acromegaly”. J Clin Neurosci 2010;17:279.

9. Khan ZH, Rasouli MR. Intubation in patients with acromegaly: experience in more than 800 patients. Eur J Anaesthesiol 2009;26:354-355.

10. Colao A. Long-term acromegaly and associated cardiovascular complications: a case-based review. Best Pract Res Clin Endocrinol Metab 2009;23:31-38.

11. Babic BB, Petakov MS, Djukic VB, Ognjanovic SI, et al. Conductive hearing loss in patients with active acromegaly. Otol Neurotol 2006;27:865-870.

12. Graham MD, Brackmann DE. Acromegaly and the temporal bone. J Laryngol Otol 1978;92:275-279.

13. Weiss V, Sonka K, Pretl M, Dostálová S, et al. Prevalence of the sleep apnea syndrome in acromegaly population. J Endocrinol Invest 2000;23:515-519.

14. Sosa E, Espinosa de-los-Monteros AL, González B, Vargas G, et al. Tratamiento de la acromegalia con octreotida LAR. Rev Med Inst Mex Seguro Soc 2008;46:651-658.